ImmunityBio is a clinical-stage biotechnology company developing advanced immunotherapies and cell-based treatments for cancer and infectious diseases. Its platform activates the body’s natural immune system using novel cytokines and vaccines. Patients with solid tumors, particularly bladder cancer, benefit from its targeted approach, which aims to improve survival and quality of life.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends